Shares of Simlatus Corp (OTCMKTS:SIML) have been exploding higher on the OTC over the past week, with the stock rising as much as 1200% in that time on a massive increase in trading volume. Helping to fuel that fire, the company just announced that its Cannabis Division, Proscere Bioscience, has signed a 5-year distribution agreement with United Opportunities, LLC in value of $175M to sell its Cold-Water Cannabis/Hemp Extraction Systems in Europe and Canada.
According to the release, “On March 29, 2019, the Board of Directors approved the Company and its subsidiary, Proscere Bioscience Inc., to enter into a Distribution Agreement with United Opportunities, LLC allowing the rights to sell the Cold-Water Cannabis/Hemp Extraction Systems within all of Canada and Europe. The term of the agreement is for five years with guaranteed minimal purchase orders of $35,000,000 per year and/or $175,000,000 over a five year period.”
Simlatus Corp (OTCMKTS:SIML) bills itself as a company that operates multiple revenue streams in the CBD Industry, Major Broadcast Industry and Internet Provider Industry.
Proscere Bioscience manufactures the first commercial industry standard cold-water CBD extraction system for medical grade cannabis utilization, along with their aeroponic commercial grade technology control containers for government food-safety programs, commercial and medical grade CBD. Satel Group is the premier high-rise DirecTV providers in the San Francisco metropolitan area, and is now expanding both DirecTV and Internet services across the SF Bay Area.
Simlatus manufactures its own proprietary systems for the major broadcast studios, such as Warner Bros., Fox News, CBS and DirecTV. Its video technology is the major system used for underwater oil exploration in the world.
Proscere Bioscience manufactures and distributes a proprietary commercial Cold-Water Cannabis/Hemp Extraction Systems. This advanced method and technology is highly effective in producing medical-grade product used to help people suffering with a wide range of ailments; from treating pain, inflammation, infections, sleep issues and mood disorders. The CBD is also proven to support the immune system, protects the brain and fights cancer.
Proscere Bioscience’s commercial Cold-Water Cannabis/Hemp Extraction Systems are expected to yield $225M over the next 5 years, based upon expected growth and application.
Find out when $SIML reaches critical levels. Subscribe to OracleDispatch.com Right Now by entering your Email in the box below.
As noted above, SIML just announced that its Cannabis Division, Proscere Bioscience, has signed a 5-year distribution agreement with United Opportunities, LLC in value of $175M to sell its Cold-Water Cannabis/Hemp Extraction Systems in Europe and Canada.
Traders will note nearly 840% during the past week in terms of shareholder gains in the stock. What’s more, the name has witnessed a pop in interest, as transaction volume levels have recently pushed greater than 1200% beyond what we have been seeing over the larger time frame.
According to its most recent release, “Shawn Illingworth is the Managing Partner of United Opportunities, LLC, and the company was formed in 2017 in overseeing the purchases of multiple cannabis farms in the Humboldt, Adelanto, Needles, Nipton, Cal City, and Searchlight areas of California and Nevada. The company currently cultivates medical grade crops on a grand scale and supply product to all the major manufacturers and extraction companies in the industry. Future plans are to expand the company and distribute internationally through attaining cultivation centers in Canada, Europe and Australia. United Opportunities is currently opening an office and showroom in Las Vegas, NV which will round out its current operating platforms in New York, Florida, and San Diego, California.”
Currently trading at a market capitalization of $166.14k, SIML has virtually no cash on the books, which compares with about $14M in total current liabilities. The company is effectively pre-revenue at this point. This may be a very interesting story and we will look forward to updating it again soon. Sign-up for continuing coverage on shares of $SIML stock, as well as other hot stock picks, get our free newsletter today and get our next breakout pick!
Disclosure: we hold no position in $SIML, either long or short, and we have not been compensated for this article.